CD36 and metabolic dysfunction-associated steatohepatitis: Interestingly, when we classify the morbidly obese cohort into NL, SS and NASH, we observed that both CD36 and FABP4 correlations with glucose metabolism parameters became stronger in NASH (CD36: Insulin r = 0.550, p = 0.010; HOMA2-IR r = 0.546, p = 0.010) (FABP4: Glucose r = 0.801, p < 0.001; Insulin r = 0.833, p < 0.001; HbA1c r = 0.893, p < 0.001; HOMA2-IR r = 0.838, p < 0.001).